M.J. Kovacs - Concepedia

Concepedia

Author

M.J. Kovacs

Western University

Also Known As

M J Kovacs, M KOVACS, M Kovacs, M Kovács, M. J. KOVACS, M. J. Kovacs, M. Kovacs, M. Kovács, M.J. KOVACS, M.J. Kovacs

54

Publications

3.4K

Citations

29

H-Index

60

Concepts

All Affiliations

Western University University of Ottawa McGill University London Health Sciences Centre Ottawa Hospital

MK

About

M.J. Kovacs is an author at Western University specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	27	2.2K
2	Public Health	14	14	922
3	Emergency Medicine	12	12	856
4	Health Sciences	3	3	311
5	Diagnostic Sciences	1	1	10

M.J. Kovacs

×

36

Publications

3.4K

Citations

28

H-Index

	Year	Citations
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy Marc Rodger, Susan R. Kahn, Philip S. Wells, Canadian Medical Association Journal	2008	571
Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study C. W. Francis, Craig M. Kessler, Samuel Z. Goldhaber, Journal of Thrombosis and Haemostasis ThrombosisDaltecan StudyVenous ThrombosisOncologyHematology	2015	239
A pilot study of central venous catheter survival in cancer patients using low‐molecular‐weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study) M.J. Kovacs, Susan R. Kahn, Marc Rodger, Journal of Thrombosis and Haemostasis ThrombosisVenous DiseaseOncologyVenous ThrombosisCardiovascular Disease	2007	205
Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis Susan R. Kahn, Clive Kearon, J.A. Julian, Journal of Thrombosis and Haemostasis ThrombosisVenous DiseaseVenous ThrombosisCardiovascular DiseaseVenous Disease Treatment	2005	204
Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial Susan R. Kahn, Ian Shrier, Susan Shapiro, Canadian Medical Association Journal	2010	158
Epoetin Alfa Therapy Increases Hemoglobin Levels and Improves Quality of Life in Patients With Cancer-Related Anemia Who Are Not Receiving Chemotherapy and Patients With Anemia Who Are Receiving Chemotherapy Ian Quirt, Christine Robeson, Catherine Y. Lau, Journal of Clinical Oncology	2001	151
Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study Rufaro S Chitsike, Marc Rodger, M.J. Kovacs, Journal of Thrombosis and Haemostasis ThrombosisVenous ThrombosisSubtherapeutic Warfarin AnticoagulationCardiovascular DiseaseVenous Disease Treatment	2012	143
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor Clive Kearon, Jeffrey S. Ginsberg, David R. Anderson, Journal of Thrombosis and Haemostasis	2004	142
Combined use of clinical assessment and d-dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study) David R. Anderson, M.J. Kovacs, George Kovács, Journal of Thrombosis and Haemostasis ThrombosisPulmonary EmbolismVenous ThrombosisCardiovascular DiseaseEdited Study	2003	137
Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency J.‐P. Galanaud, Christina Holcroft, Marc Rodger, Journal of Thrombosis and Haemostasis ThrombosisPulmonary EmbolismVenous DiseaseVenous ThrombosisPrimary Venous Insufficiency	2012	121

Page 1